Cargando…
Clinical Management of Localized Colon Cancer with Capecitabine
Large randomized trials demonstrated a benefit of adjuvant chemotherapy after resection of the primary colon cancer. It improves overall survival and reduces the risk of death, by 5% in UICC (Union Internationale Contre le Cancer) stage II and approximately 15%–20% in stage III. Fluoropyrimidines ha...
Autores principales: | Quidde, J., Arnold, D., Stein, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498969/ https://www.ncbi.nlm.nih.gov/pubmed/23170068 http://dx.doi.org/10.4137/CMO.S8194 |
Ejemplares similares
-
Use of capecitabine in management of early colon cancer
por: Hameed, H, et al.
Publicado: (2011) -
Capecitabine in the management of colorectal cancer
por: Hirsch, Bradford R, et al.
Publicado: (2011) -
Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer - results from a non-interventional observation study
por: Stein, Alexander, et al.
Publicado: (2016) -
Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer
por: Kaufman, Bella, et al.
Publicado: (2008) -
Retrospective study of preoperative chemoradiotherapy with capecitabine versus capecitabine plus oxaliplatin for locally advanced rectal cancer
por: Yang, Xiao-Hui, et al.
Publicado: (2020)